Surgical management of infective endocarditis: Early and long-term mortality analysis. single- center experience and brief literature review

Hellenic Journal of Cardiology

Volumn 55, Issue 6, 2014, Pages 462-474

  Spiliopoulos, Kyriakos ^a,b   Giamouzis, Gregory ^c   Haschemi, Ayman ^a   Karangelis, Dimos ^b   Antonopoulos, Nikolaos ^b   Fink, Gabriel ^a   Kemkes, Bernhard M ^a   Gansera, Brigitte ^a  

^a Chirurgische Klinik Munchen Bogenhausen   (Germany)

^b Department of Thoracic and Cardiovascular Surgery ^*  (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Infective endocarditis; Mortality analysis; Surgical treatment

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; CAUSE OF DEATH; ENDOCARDITIS; FEMALE; FOLLOW UP; GREECE; HEART VALVE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PROCEDURES; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDY; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; SURGERY; SURVIVAL RATE;

ADULT; AGED; CAUSE OF DEATH; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; GREECE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE;

EID: 84912098238     PISSN: 11099666     EISSN: 22415955     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Eykyn SJ. Endocarditis: basics. Heart. 2001; 86: 476-480.
2. Habib G. Management of infective endocarditis. Heart. 2006; 92: 124-130.
3. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010; 121: 1141-1152.
4. Spiliopoulos K, Bagiatis V, Deutsch O, et al. Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement. Gen Thorac Cardiovasc Surg. 2014; 62: 103-111.
5. Spiliopoulos K, Haschemi A, Fink G, Kemkes BM. Infective endocarditis complicated by paravalvular abscess: a surgical challenge. An 11-year single center experience. Heart Surg Forum. 2010; 13: E67-73.
6. Olaison L, Pettersson G. Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am. 2002; 16: 453-475.
7. Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011; 141: 98-106.e1-2.
8. Funakoshi S, Kaji S, Yamamuro A, et al. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg. 2011; 142: 836-842.e1.
9. Murdoch DR, Corey GR, Hoen B, et al; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009; 169: 463-473.
10. Habib G, Hoen B, Tornos P, et al; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009; 30: 2369-2413.
11. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005; 111: e394-434.
12. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011; 32: 2027-2033.
13. Delahaye F, Alla F, Béguinot I, et al; AEPEI Group. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis. 2007; 39: 849-857.
14. Fayad G, Leroy G, Devos P, et al. Characteristics and prognosis of patients requiring valve surgery during active infective endocarditis. J Heart Valve Dis. 2011; 20: 223-228.
15. Revilla A, López J, Vilacosta I, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J. 2007; 28: 65-71.
16. Hoen B, Selton-Suty C, Lacassin F, et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995; 20: 501-506.
17. Manne MB, Shrestha NK, Lytle BW, et al. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis. Ann Thorac Surg. 2012; 93: 489-493.
18. San Román JA, López J, Vilacosta I, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007; 120: 369.e1-7.
19. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J. 2007; 28: 196-203.
20. Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart. 2005; 91: 954-959.
21. Lebreton G, Merle S, Inamo J, et al. Limitations in the interobserver reliability of EuroSCORE: what should change in EuroSCORE II? Eur J Cardiothorac Surg. 2011; 40: 1304-1308.
22. Basraon J, Chandrashekhar YS, John R, et al. Comparison of risk scores to estimate perioperative mortality in aortic valve replacement surgery. Ann Thorac Surg. 2011; 92: 535-540.
23. Spiliopoulos K, Haschemi A, Parasiris P, Kemkes BM. Sorin Bicarbon bileaflet valve: a 9.8-year experience. Clinical performance of the prosthesis after heart valve replacement in 587 patients. Interact Cardiovasc Thorac Surg. 2009; 8: 252-259.
24. Gansera B, Hapfelmeier A, Brandl K, Spiliopoulos K, Gundling F, Eichinger W. The Mosaic bioprosthesis in the aortic position: 17 years’ results. Thorac Cardiovasc Surg. 2014; 62: 26-34.
25. Perrotta S, Aljassim O, Jeppsson A, Bech-Hanssen O, Svensson G. Survival and quality of life after aortic root replacement with homografts in acute endocarditis. Ann Thorac Surg. 2010; 90: 1862-1867.
26. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation. 1994; 90 (5 Pt 2): 198-204.
27. David TE, Regesta T, Gavra G, Armstrong S, Maganti MD. Surgical treatment of paravalvular abscess: long-term results. Eur J Cardiothorac Surg. 2007; 31: 43-48.
28. Tleyjeh I, Steckelberg J, Georgescu G, et al. The association between the timing of valve surgery and six-month mortality in left-sided infective endocarditis. Heart. 2008; 94: 892-896.
29. Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007; 44: 364-372.
30. Algarni KD, Elhenawy AM, Maganti M, Collins S, Yau TM. Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: trends over 18 years. J Thorac Cardiovasc Surg. 2012; 144: 340-6, 346.e1.
31. Ota T, Gleason TG, Salizzoni S, Wei LM, Toyoda Y, Bermudez C. Midterm surgical outcomes of noncomplicated active native multivalve endocarditis: single-center experience. Ann Thorac Surg. 2011; 91: 1414-1419.
32. Musci M, Hübler M, Amiri A, et al. Surgical treatment for active infective prosthetic valve endocarditis: 22-year single-centre experience. Eur J Cardiothorac Surg. 2010; 38: 528-538.
33. Wang A, Athan E, Pappas PA, et al. International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007; 297: 1354-1361.
34. Remadi JP, Habib G, Nadji G, et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg. 2007; 83: 1295-1302.
35. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003; 290: 3207-3214.
36. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003; 289: 1933-1940.
37. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002; 88: 53-60.
38. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011; 32: 2027-2033.